We are live on
!
Find out more
Fidelity International Portfolio holdings
AUM
$129B
1-Year Est. Return
30.83%
This Fund
S&P 500
This Quarter
Est. Return
+11.95%
1 Year Est. Return
+30.83%
3 Year Est. Return
+84.29%
5 Year Est. Return
+110%
10 Year Est. Return
+535.69%
AUM
$24.8B
AUM Growth
+$3.92B
(+19%)
Cap. Flow
+$1.77B
Cap. Flow
% of AUM
7.15%
Top 10 Holdings %
Top 10 Hldgs %
19.71%
Holding
613
New
70
Increased
229
Reduced
209
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$209M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$169M |
| 3 |
CVS Health
CVS
|
+$135M |
| 4 |
Conagra Brands
CAG
|
+$131M |
| 5 |
Ambev
ABEV
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$250M |
| 2 |
Transocean
RIG
|
+$168M |
| 3 |
ABV
COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH
ABV
|
+$133M |
| 4 |
Johnson & Johnson
JNJ
|
+$112M |
| 5 |
Capital One
COF
|
+$96.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.31% |
| 2 | Technology | 13.6% |
| 3 | Financials | 12.35% |
| 4 | Consumer Staples | 9.96% |
| 5 | Communication Services | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
176
DELISTED
Celgene Corp
CELG
| $30.3M | 0.12% |
358,994
-286,582
| -44% | -$22.7M |
|
177
Verizon
VZ
$194B
| $30M | 0.12% |
611,041
+63,910
| +12% | +$3.14M |
|
178
EOG Resources
EOG
$78B
| $30M | 0.12% |
356,952
-634,064
| -64% | -$54.3M |
|
179
FirstCash
FCFS
$8.55B
| $29.7M | 0.12% |
480,109
+1,501
| +0.3% | +$90.8K |
|
180
Brown-Forman Class B
BF.B
$12B
| $29.5M | 0.12% |
1,219,375
+22,500
| +2% | +$528K |
|
|
ISS
181
DELISTED
ISOFTSTONE HLDGS LTD ADS EACH REPSTG 10 ORD SHS (CYM)
ISS
| $29.5M | 0.12% |
5,752,325
| – | – |
|
|
SPLS
182
DELISTED
Staples Inc
SPLS
| $29.4M | 0.12% |
1,849,581
+333,209
| +22% | +$5.19M |
|
183
The Mosaic Company
MOS
$7.09B
| $29.4M | 0.12% |
621,276
+190,819
| +44% | +$8.85M |
|
184
SK Telecom
SKM
$13.7B
| $29.3M | 0.12% |
721,975
+43,964
| +6% | +$1.73M |
|
|
BNY
185
Bank of New York Mellon
BNY
$108B
| $29.2M | 0.12% |
835,017
+9,681
| +1% | +$315K |
|
186
HCA Healthcare
HCA
$84.8B
| $27.8M | 0.11% |
583,437
+320,714
| +122% | +$14.8M |
|
187
Henry Schein
HSIC
$9.74B
| $27.8M | 0.11% |
619,714
-122,206
| -16% | -$5.35M |
|
188
Invesco
IVZ
$13.3B
| $27.4M | 0.11% |
751,750
+411,950
| +121% | +$14M |
|
189
Qualcomm
QCOM
$176B
| $27.3M | 0.11% |
+367,910
| New | +$25.9M |
|
|
DANG
190
DELISTED
E-COMMERCE CHINA DANGDANG INC SPNSRD ADS REP COM CL A (CYM)
DANG
| $26.5M | 0.11% |
2,778,457
+1,486,182
| +115% | +$14.1M |
|
|
SNDK
191
DELISTED
SANDISK CORP
SNDK
| $26.5M | 0.11% |
375,000
| – | – |
|
192
General Dynamics
GD
$105B
| $26.1M | 0.11% |
273,567
+92,467
| +51% | +$8.26M |
|
|
MRSH
193
Marsh
MRSH
$86.3B
| $25.9M | 0.1% |
535,878
-94,805
| -15% | -$4.39M |
|
194
AT&T
T
$165B
| $25.7M | 0.1% |
968,376
+24,998
| +3% | +$658K |
|
|
MHFI
195
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $25.4M | 0.1% |
325,000
-2,000
| -0.6% | -$144K |
|
196
Teva Pharmaceuticals
TEVA
$35.9B
| $25.1M | 0.1% |
625,496
+265,696
| +74% | +$10.5M |
|
|
SIRO
197
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
| $24.9M | 0.1% |
354,600
| – | – |
|
|
NE
198
DELISTED
Noble Corporation
NE
| $24.7M | 0.1% |
754,746
+41,500
| +6% | +$1.38M |
|
199
Children's Place
PLCE
$53.6M
| $24.5M | 0.1% |
430,109
+29,035
| +7% | +$1.57M |
|
|
NAV
200
DELISTED
Navistar International
NAV
| $24.4M | 0.1% |
639,489
+66,933
| +12% | +$2.56M |
|
Similar funds
Fidelity International's Q4 2013 Portfolio in Review
As of Q4 2013, Fidelity International held 613 positions worth $24.8B, up 19% from $20.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Fidelity International deployed $1.77B of net new capital in Q4 2013, opening 70 new positions and adding to 229 existing holdings. Its largest new stake was Conagra Brands: 5,248,985 shares worth $138M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Merck, an estimated $250M trimmed.
- Fidelity International's largest Q4 2013 buy was Conagra Brands: 5,248,985 shares worth $138M.
- Fidelity International added most to AbbVie in Q4 2013, an estimated $209M increase.
- Fidelity International's biggest Q4 2013 reduction was Merck, cutting an estimated $250M.
- Fidelity International fully exited COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH in Q4 2013, selling an estimated $133M.
- Fidelity International's ten largest holdings make up 20% of its $24.8B portfolio in Q4 2013.
- Fidelity International opened 70 new positions and closed 84 in Q4 2013.
- Fidelity International's portfolio value rose 19% quarter-over-quarter to $24.8B.
Based on Fidelity International's 13F filing for Q4 2013, filed 13 Feb 2014.